Winner Profile
Yulin Wei

CEO, Sinopharm

Industry: Health Care Distributors

Company size: XX-Large
Published: 2016-10-17

Is Sinopharm a good stock investment?

Obermatt Stock Research Sinopharm


Based on the annual Obermatt CEO of the Year analysis, Yulin Wei (Sinopharm) earned the following Obermatt pins for the management performance.

Obermatt accolades Yulin Wei

Yulin Wei was included in the competition among China 100 Ranking (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.

Performance Overview Yulin Wei

In summary, Yulin Wei obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):

CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 85 in Combined Performance indicates that Yulin Wei was better than 85% of all other CEOs that were analyzed as part of the China 100 Ranking – China for 4 participations in Obermatt CEO competitions. Yulin Wei’s average ranking can be found in the Multi-Year Rankings for China 100 Ranking - China.